KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Return on Invested Capital (2021 - 2025)

Rigel Pharmaceuticals (RIGL) has 4 years of Return on Invested Capital data on record, last reported at 1.33% in Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 1263.0% year-over-year to 1.33%; the TTM value through Dec 2025 reached 1.33%, up 1263.0%, while the annual FY2025 figure was 1.75%, 599.0% up from the prior year.
  • Return on Invested Capital reached 1.33% in Q4 2025 per RIGL's latest filing, up from 0.94% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 6.72% in Q3 2022 and bottomed at 51.4% in Q2 2022.
  • Average Return on Invested Capital over 4 years is 4.61%, with a median of 0.12% recorded in 2021.
  • Peak YoY movement for Return on Invested Capital: crashed -5134bps in 2022, then soared 1263bps in 2025.
  • A 4-year view of Return on Invested Capital shows it stood at 0.32% in 2021, then surged by 2179bps to 6.72% in 2022, then plummeted by -268bps to 11.3% in 2024, then surged by 112bps to 1.33% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 1.33% in Q4 2025, 0.94% in Q3 2025, and 1.5% in Q2 2025.